Literature DB >> 15484320

Proteomic analysis of blood level of proteins before and after operation in patients with esophageal squamous cell carcinoma at high-incidence area in Henan Province.

Ji-Ye An1, Zong-Min Fan, Ze-Hao Zhuang, Yan-Ru Qin, Shan-Shan Gao, Ji-Lin Li, Li-Dong Wang.   

Abstract

AIM: To characterize the protein files in blood from same patients with esophageal squamous cell carcinoma (ESCC) before and after operation at the high-incidence area for ESCC in Henan Province, China.
METHODS: Two-dimensional electrophoresis, silver staining and ImageMaster 2-DE analysis software were applied to the determination of protein files in the blood obtained from normal controls and ESCC patients before and after operation.
RESULTS: A total of 655, 662 and 677 protein spots were identified, respectively, from the normal controls and ESCC patients before and after operation. No significant difference in the number of protein spots was observed between the normal group and ESCC patients. A total of seven protein spots were identified with a dramatic difference among the samples before and after operation. Six protein spots were up-regulated and one protein spot was down-regulated in the group after operation compared with those in normal and before operation. Three protein spots were further characterized by matrix-assisted laser desorption/ionization time of flying mass spectrometry (MALDI-TOF-MS). The proteins from these three spots were identified as serum amyloid A (SAA), amyloid related serum protein and haptoglobin.
CONCLUSION: Serum amyloid A, amyloid related serum protein and haptoglobin may be related with ESCC and/or surgery. The significance of these proteins needs to be further characterized. The present study provides informative data for the establishment of serum protein profiles related with ESCC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15484320      PMCID: PMC4572315          DOI: 10.3748/wjg.v10.i22.3365

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

1.  Induction and regulation of acute phase proteins in transdifferentiated hepatocytes.

Authors:  Juliya K Kurash; Chia Ning Shen; David Tosh
Journal:  Exp Cell Res       Date:  2004-01-15       Impact factor: 3.905

2.  The effect of supplementation with an antioxidant preparation on LDL-oxidation is determined by haptoglobin polymorphism.

Authors:  Dirk Bernard; Armand Christophe; Joris Delanghe; Michel Langlois; Marc De Buyzere; Frank Comhaire
Journal:  Redox Rep       Date:  2003       Impact factor: 4.412

3.  Significance of serum amyloid A on the prognosis in patients with renal cell carcinoma.

Authors:  M Kimura; Y Tomita; T Imai; T Saito; A Katagiri; Y Ohara-Mikami; T Matsudo; K Takahashi
Journal:  Cancer       Date:  2001-10-15       Impact factor: 6.860

4.  Integrating cancer genomics and proteomics in the post-genome era.

Authors:  Samir M Hanash; Miroslav P Bobek; David S Rickman; Tom Williams; Jean Marie Rouillard; Rork Kuick; Eric Puravs
Journal:  Proteomics       Date:  2002-01       Impact factor: 3.984

5.  Serum amyloid A protein (SAA) in colorectal carcinoma.

Authors:  I Glojnarić; M T Casl; D Simić; J Lukac
Journal:  Clin Chem Lab Med       Date:  2001-02       Impact factor: 3.694

6.  Intervention and follow-up on human esophageal precancerous lesions in Henan, northern China, a high-incidence area for esophageal cancer.

Authors:  Li Dong Wang; Qi Zhou; Chang Wei Feng; Bin Liu; Yi Jun Qi; Yan Run Zhang; Shan Shan Gao; Zong Min Fan; Yun Zhou; Chang S Yang; Jun Ping Wei; Shu Zheng
Journal:  Gan To Kagaku Ryoho       Date:  2002-02

Review 7.  Regulation of serum amyloid A protein expression during the acute-phase response.

Authors:  L E Jensen; A S Whitehead
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

8.  Use of somatic cell hybrids and fluorescence in situ hybridization to localize the functional serum amyloid A (SAA) genes to chromosome 11p15.4-p15.1 and the entire SAA superfamily to chromosome 11p15.

Authors:  G Watson; C G See; P Woo
Journal:  Genomics       Date:  1994-10       Impact factor: 5.736

9.  Regulation of the human acute phase serum amyloid A genes by tumour necrosis factor-alpha, interleukin-6 and glucocorticoids in hepatic and epithelial cell lines.

Authors:  C F Thorn; Z-Y Lu; A S Whitehead
Journal:  Scand J Immunol       Date:  2004-02       Impact factor: 3.487

10.  Inhibition of angiogenesis, tumour growth and experimental metastasis of human fibrosarcoma cells HT1080 by a multimeric form of the laminin sequence Tyr-Ile-Gly-Ser-Arg (YIGSR).

Authors:  Y Iwamoto; M Nomizu; Y Yamada; Y Ito; K Tanaka; Y Sugioka
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

View more
  10 in total

1.  Haptoglobin is a serological biomarker for adenocarcinoma lung cancer by using the ProteomeLab PF2D combined with mass spectrometry.

Authors:  You-Kang Chang; Yu-Heng Lai; Yen Chu; Ming-Cheng Lee; Chun-Yao Huang; Semon Wu
Journal:  Am J Cancer Res       Date:  2016-08-01       Impact factor: 6.166

2.  Mutation screening of mismatch repair gene Mlh3 in familial esophageal cancer.

Authors:  Hong-Xu Liu; Yu Li; Xue-Dong Jiang; Hong-Nian Yin; Lin Zhang; Yu Wang; Jun Yang
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

3.  Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer.

Authors:  Changqing Zhao; Loganath Annamalai; Changfa Guo; Narasimhan Kothandaraman; Stephen Chee Liang Koh; Huoming Zhang; Arijit Biswas; Mahesh Choolani
Journal:  Neoplasia       Date:  2007-01       Impact factor: 5.715

Review 4.  Human body fluid proteome analysis.

Authors:  Shen Hu; Joseph A Loo; David T Wong
Journal:  Proteomics       Date:  2006-12       Impact factor: 3.984

5.  Potential biomarkers in the sera of breast cancer patients from bahawalpur, pakistan.

Authors:  Faiz-Ul-Hassan Nasim; Samina Ejaz; Muhammad Ashraf; Abdul Rehman Asif; Michael Oellerich; Gulzar Ahmad; Gulzar Ahmad Malik
Journal:  Biomark Cancer       Date:  2012-12-10

6.  Overexpression of PRR11 promotes tumorigenic capability and is associated with progression in esophageal squamous cell carcinoma.

Authors:  Li Zhou; Zhe-Zhi Deng; Hai-Yan Li; Nan Jiang; Zhi-Sheng Wei; Ming-Fan Hong; Ji-Hui Wang; Ming-Xing Zhang; Yi-Hua Shi; Zheng-Qi Lu; Xu-Ming Huang
Journal:  Onco Targets Ther       Date:  2019-04-09       Impact factor: 4.147

7.  Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma.

Authors:  Jun-Ye Wang; Yu-Zhen Zheng; Juan Yang; Yue-Hao Lin; Shu-Qin Dai; Ge Zhang; Wan-Li Liu
Journal:  BMC Cancer       Date:  2012-08-23       Impact factor: 4.430

Review 8.  The current state of proteomics in GI oncology.

Authors:  Ying Lin; William S Dynan; Jeffrey R Lee; Zhao-Hua Zhu; Robert R Schade
Journal:  Dig Dis Sci       Date:  2008-12-23       Impact factor: 3.199

9.  Proteomic identification of fucosylated haptoglobin alpha isoforms in ascitic fluids and its localization in ovarian carcinoma tissues from Mexican patients.

Authors:  Olga Lilia Garibay-Cerdenares; Verónica Ivonne Hernández-Ramírez; Juan Carlos Osorio-Trujillo; Magdalena Hernández-Ortíz; Dolores Gallardo-Rincón; David Cantú de León; Sergio Encarnación-Guevara; Julio César Villegas-Pineda; Patricia Talamás-Rohana
Journal:  J Ovarian Res       Date:  2014-02-27       Impact factor: 4.234

10.  Haptoglobin and CCR2 receptor expression in ovarian cancer cells that were exposed to ascitic fluid: exploring a new role of haptoglobin in the tumoral microenvironment.

Authors:  O L Garibay-Cerdenares; V I Hernández-Ramírez; J C Osorio-Trujillo; D Gallardo-Rincón; P Talamás-Rohana
Journal:  Cell Adh Migr       Date:  2015-07-25       Impact factor: 3.405

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.